Partial List of Speakers (2017)
|Duu-Gong Wu, Ph.D.
Former Deputy Division Director, CDER, FDA, USA
|Dana Ault-Riche, Ph.D.
Co-Founder and CEO, Reflexion Pharmaceuticals, USA
|David Lin, Ph.D.
Senior consultant, Former Acting Deputy Division Director, CDER, FDA Biologics Consulting Group, USA
|Christopher A. Rhodes, Ph.D.
President and CEO, President of Boulder Peptide Symposium, Drug Delivery Experts, USA
|Anthony Partridge Ph.D.
Principal Scientist, Merck, USA
|Soumitra Ghosh, Ph.D.
Co-founder and CSO, President of Peptide Therapeutic Foundation, Avexegen Therapeutics, USA
|Richard Pittner, Ph.D.
Co-Founder, OXT Therapeutics and BioShore Partners, USA
|Ranjan Chakrabarti, Ph.D.
Vice President and Global Head of Biologics Lab Operations, USP, USA
|Zhaohui (Zoe) Wang, Ph.D.|
J.D., Partner, Co-head of patent practice group, JunHe, China and USA
Peptide Therapeutics Talks
Talks and discussions covering the development of peptide therapeutics are key parts to our symposium. In addition, we hold special panels covering topics that include regulatory affairs, quality assurance, and venture capitial investments. The panels feature discussions from FDA, CFDA and USP experts on evolving regulatory environments in the pharmaceutical industry.